Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Pommier

Showing results (1-10 of 251) with videos related to

Pageof 26
Sort By:
Seminars in Oncology|February 1, 1996
Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecinsY Pommier
Biochimie|June 6, 1998
Diversity of DNA topoisomerases I and inhibitorsY Pommier
Cancer Chemotherapy and Pharmacology|January 1, 1993
DNA topoisomerase I and II in cancer chemotherapy: update and perspectivesY Pommier
La Revue Du Praticien|October 1, 1981
[Methotrexate]Y Pommier, F Lokiec
Cancer Research|April 1, 1992
Topoisomerase I alteration in a camptothecin-resistant cell line derived from Chinese hamster DC3F cells in cultureA Tanizawa, Y Pommier
Advances in Cancer Research|October 18, 2000
Topoisomerase I-mediated DNA damageP Pourquier, Y Pommier
Experimental Cell Research|August 1, 1996
DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studiesT Shimizu, Y Pommier
Leukemia|August 1, 1997
Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteasesT Shimizu, Y Pommier
Nucleic Acids Research|August 11, 1995
Processing of deoxyuridine mismatches and abasic sites by human immunodeficiency virus type-1 integraseA Mazumder, Y Pommier
Bulletin Du Cancer|February 5, 1999
[Topoisomerases I: new targets for the treatment of cancer and mechanisms of resistance]P Pourquier, Y Pommier
Pageof 26

Showing results (1-10 of 251) with videos related to

Sort By:
Pageof 26
Seminars in Oncology|February 1, 1996
Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecinsY Pommier
Biochimie|June 6, 1998
Diversity of DNA topoisomerases I and inhibitorsY Pommier
Cancer Chemotherapy and Pharmacology|January 1, 1993
DNA topoisomerase I and II in cancer chemotherapy: update and perspectivesY Pommier
La Revue Du Praticien|October 1, 1981
[Methotrexate]Y Pommier, F Lokiec
Cancer Research|April 1, 1992
Topoisomerase I alteration in a camptothecin-resistant cell line derived from Chinese hamster DC3F cells in cultureA Tanizawa, Y Pommier
Advances in Cancer Research|October 18, 2000
Topoisomerase I-mediated DNA damageP Pourquier, Y Pommier
Experimental Cell Research|August 1, 1996
DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studiesT Shimizu, Y Pommier
Leukemia|August 1, 1997
Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteasesT Shimizu, Y Pommier
Nucleic Acids Research|August 11, 1995
Processing of deoxyuridine mismatches and abasic sites by human immunodeficiency virus type-1 integraseA Mazumder, Y Pommier
Bulletin Du Cancer|February 5, 1999
[Topoisomerases I: new targets for the treatment of cancer and mechanisms of resistance]P Pourquier, Y Pommier
Pageof 26